WINDLAS Biotech Private Limited, founded in 2001, operates globally and is committed to developing, manufacturing and marketing drugs of high therapeutic value for human consumption. Our company has three major verticals – Contract Manufacturing, Contract Development (for both Indian markets and exports) and branded generic formulation development. Windlas Biotech operates two WHO-GMP approved plants in Dehradun, which cater to the contract manufacturing requirements of many domestic formulators including Mankind, Emcure Pharma, Zuventus, Biocon, Ranbaxy and other companies in this sector. We continue to partner with several domestic pharmaceutical companies, and facilitate product filings in the developing market (RoW) with the aim of catering to the local players. Moreover, we have a significant presence in contract manufacturing in other parts of Asia and in Africa through our local partners in these countries.Our corporate headquarters is in Gurgaon, NCR (India). A wholly owned subsidiary, Windlas Healthcare Private Limited (WHC) engages in manufacturing generic products for regulated markets like United States and Europe. We have been active for many years in the contract manufacturing business, offering a wide range of services for pharmaceuticals production